From new drug candidates and predictive cell culture models to development and manufacturing of innovative (bio-)pharmaceuticals to nanobiomedical applications.
Besonderheiten des PRAXISforums Von Experten für Experten - Hören Sie Erlebnisberichte und konkrete Lösungsvorschläge von namenhaften...
Manufacturing, vectors, applications & regulatory aspects
The upcoming Advances in Chemical Biology conference will feature latest research from all hot topics in chemical biology. Lectures by young researchers and...
In September 2018, the 3rd European Conference on Natural Products will again feature recent advances in secondary metabolite research. With a special...
How close to in vivo can we get? Get updated about 3D cell cultures as predictive, physiological relevant model systems! Since our first symposium in...
The biopharmaceutical industry has developed rapidly in recent decades, with biotechnologically manufactured drugs are at the top both in new approvals and new fields of application. Various trends such as the production of biosimilars have led to a real boom in new production facilities in recent years.
Pharmaceutical companies are increasingly planning and constructing more flexible, smaller plants to meet the demand. These flexible Facilities of the Future (FoF) often use single-use systems. The Status Paper of the DECHEMA working group “Single-use technology in biopharmaceutical manufacturing” is an introduction in the field.
(former Status Seminar Chemical Biology )
Colloquium on 18.10.2017 at Campus Berlin-Buch. The colloquium is organised by Berlin Partner for Business and Technology GmbH, Campus Berlin-Buch, and supported by DECHEMA e.V.
Speaker: Dr. Ronny Schmidt, Sciomics GmbH, Heidelberg/D Innovative biomarker signatures are a cornerstone of precision medicine especially in the immune...
Rückblick auf den 10. Bundesalgenstammtisch in Merseburg Optimierung von Produktionsverfahren mit Mikroalgen Produktionskosten sind der...